Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Preligand assembly domain-mediated ligand-independent association between TRAIL receptor 4 (TR4) and TR2 regulates TRAIL-induced apoptosis.

Clancy L, Mruk K, Archer K, Woelfel M, Mongkolsapaya J, Screaton G, Lenardo MJ, Chan FK.

Proc Natl Acad Sci U S A. 2005 Dec 13;102(50):18099-104. Epub 2005 Nov 30.

2.

Activated human NK and CD8+ T cells express both TNF-related apoptosis-inducing ligand (TRAIL) and TRAIL receptors but are resistant to TRAIL-mediated cytotoxicity.

Mirandola P, Ponti C, Gobbi G, Sponzilli I, Vaccarezza M, Cocco L, Zauli G, Secchiero P, Manzoli FA, Vitale M.

Blood. 2004 Oct 15;104(8):2418-24. Epub 2004 Jun 17.

3.
4.

Regulation of tumour necrosis factor-related apoptosis-inducing ligand (TRAIL) and TRAIL receptor expression in human neutrophils.

Kamohara H, Matsuyama W, Shimozato O, Abe K, Galligan C, Hashimoto S, Matsushima K, Yoshimura T.

Immunology. 2004 Feb;111(2):186-94.

5.

A human scFv antibody against TRAIL receptor 2 induces autophagic cell death in both TRAIL-sensitive and TRAIL-resistant cancer cells.

Park KJ, Lee SH, Kim TI, Lee HW, Lee CH, Kim EH, Jang JY, Choi KS, Kwon MH, Kim YS.

Cancer Res. 2007 Aug 1;67(15):7327-34.

6.

Protein kinase C modulates tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by targeting the apical events of death receptor signaling.

Harper N, Hughes MA, Farrow SN, Cohen GM, MacFarlane M.

J Biol Chem. 2003 Nov 7;278(45):44338-47. Epub 2003 Aug 14.

7.

Differential inhibition of TRAIL-mediated DR5-DISC formation by decoy receptors 1 and 2.

Mérino D, Lalaoui N, Morizot A, Schneider P, Solary E, Micheau O.

Mol Cell Biol. 2006 Oct;26(19):7046-55.

9.

TRAIL induces death of human oligodendrocytes isolated from adult brain.

Matysiak M, Jurewicz A, Jaskolski D, Selmaj K.

Brain. 2002 Nov;125(Pt 11):2469-80.

PMID:
12390973
10.

Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells.

Wendling U, Walczak H, Dörr J, Jaboci C, Weller M, Krammer PH, Zipp F.

Cell Death Differ. 2000 Jul;7(7):637-44.

11.

Tissue distribution of the death ligand TRAIL and its receptors.

Spierings DC, de Vries EG, Vellenga E, van den Heuvel FA, Koornstra JJ, Wesseling J, Hollema H, de Jong S.

J Histochem Cytochem. 2004 Jun;52(6):821-31.

PMID:
15150291
12.

Human astrocytes are resistant to Fas ligand and tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis.

Song JH, Bellail A, Tse MC, Yong VW, Hao C.

J Neurosci. 2006 Mar 22;26(12):3299-308. Erratum in: J Neurosci. 2006 May 3;26(18):4983.

13.
14.
15.

Sensitization to TRAIL-induced apoptosis and modulation of FLICE-inhibitory protein in B chronic lymphocytic leukemia by actinomycin D.

Olsson A, Diaz T, Aguilar-Santelises M, Osterborg A, Celsing F, Jondal M, Osorio LM.

Leukemia. 2001 Dec;15(12):1868-77.

PMID:
11753607
17.

Expression of TRAIL and TRAIL receptors in normal and malignant tissues.

Daniels RA, Turley H, Kimberley FC, Liu XS, Mongkolsapaya J, Ch'En P, Xu XN, Jin BQ, Pezzella F, Screaton GR.

Cell Res. 2005 Jun;15(6):430-8.

18.

Apoptosis-mediating receptor-ligand systems in human retinal pigment epithelial cells.

Hueber A, Aduckathil S, Kociok N, Welsandt G, Dinslage S, Kirchhof B, Esser PJ.

Graefes Arch Clin Exp Ophthalmol. 2002 Jul;240(7):551-6. Epub 2002 Jun 20.

PMID:
12136286
19.
20.

Regulation of tumor necrosis factor-related apoptosis-inducing ligand sensitivity in primary and transformed human keratinocytes.

Leverkus M, Neumann M, Mengling T, Rauch CT, Bröcker EB, Krammer PH, Walczak H.

Cancer Res. 2000 Feb 1;60(3):553-9.

Supplemental Content

Support Center